Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer

Bibliographic Details
Main Author: N. Harbeck
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Breast
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977621000497
_version_ 1819120960590053376
author N. Harbeck
author_facet N. Harbeck
author_sort N. Harbeck
collection DOAJ
first_indexed 2024-12-22T06:28:58Z
format Article
id doaj.art-de82bb1630ce4397b0ab7930e99bef57
institution Directory Open Access Journal
issn 1532-3080
language English
last_indexed 2024-12-22T06:28:58Z
publishDate 2021-04-01
publisher Elsevier
record_format Article
series Breast
spelling doaj.art-de82bb1630ce4397b0ab7930e99bef572022-12-21T18:35:45ZengElsevierBreast1532-30802021-04-0156S3S4Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancerN. Harbeckhttp://www.sciencedirect.com/science/article/pii/S0960977621000497
spellingShingle N. Harbeck
Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer
Breast
title Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer
title_full Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer
title_fullStr Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer
title_full_unstemmed Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer
title_short Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer
title_sort neoadjuvant and adjuvant treatment of patients with her2 positive early breast cancer
url http://www.sciencedirect.com/science/article/pii/S0960977621000497
work_keys_str_mv AT nharbeck neoadjuvantandadjuvanttreatmentofpatientswithher2positiveearlybreastcancer